A high-level delegation led by Mr. Kihwan Oh, Senior Managing Director, Industry Policy Division, KoreaBIO (https://www.koreabio.org/en/ ) visited the ABLE Office to explore for collaboration and market opportunities between Korean and Indian biotech companies. The meeting focused on India’s rapidly expanding biopharma market, with ABLE President Mr G S Krishnan offering valuable perspectives on the current landscape and future trends. This engagement marks a significant step towards strengthening the ties between the Korean and Indian biotech ecosystems.

The meeting focused on India’s rapidly expanding biopharma market.